Last month, the U.S. Food and Drug Administration (FDA) issued the final guidance “Homeopathic Drug Products,” which describes the agency’s approach toward prioritizing regulatory actions against ...
The U.S. Food and Drug Administration (FDA) recently issued a Warning Letter citing a failure to obtain marketing authorization via a premarket approval (PMA) or 510(k) clearance as well as Good ...
New Delhi: The Drug Controller General of India (DCGI), is set to instruct states and Union territories to identify and take action against drugmakers failing to adhere to Good Manufacturing Practices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback